Next Article in Journal
Acute kidney injury in pediatric patients: experience of a single center during an 11-year period
Previous Article in Journal
Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Open AccessArticle

HLA class II alleles and haplotypes in Lithuanian children with type 1 diabetes and healthy children (HLA and type 1 diabetes)

1
Institute of Endocrinology, Kaunas University of Medicine
2
Department of Preventive Medicine, Kaunas University of Medicine
3
Department of Endocrinology, Kaunas University of Medicine, Lithuania
4
Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden
5
Division of Pediatrics and Diabetes Research Center, Department of Clinical and Experimental Medicine, Linkoping University, Sweden
*
Author to whom correspondence should be addressed.
Medicina 2010, 46(8), 505; https://doi.org/10.3390/medicina46080072
Received: 23 November 2009 / Accepted: 6 August 2010 / Published: 11 August 2010
Objective. Type 1 diabetes mellitus is a slowly progressive autoimmune disease. The genetic background of type 1 diabetes mellitus is polygenic with the major disease locus located in the human leukocytes antigen (HLA) region. High risk and protective alleles, haplotypes, and genotypes have been determined in Lithuanian children with type 1 diabetes mellitus and healthy children.
Material and methods. In this case-control study, 124 children with diabetes (55 males and 69 females; mean age, 9.2±3.9 years) were tested for HLA class II and compared with 78 healthy controls (43 males and 35 females; mean age, 10.8±3.4 years; range, 0–15 years). HLA DRB1, DQA1, and DQB1 alleles were genotyped using a polymerase chain reaction.
Results. T1D risk-associated haplotypes (DR4)-DQA1*0301-DQB1*0302, (DR3)- DQA1*0501-DQB1*0201, and (DR1)-DQA1*0101-04-DQB1*0501 were more prevalent among children with diabetes than controls (50.0%, 41.1%, and 37.9% vs. 10.3%, 5.1%, and 24.4%, P<0.001). The haplotypes (DR4)-DQA1*0301-DQB1*0302 and (DR3)-DQA1*0501-DQB1*0201 increased T1D risk by 8.75 and 12.93 times, respectively (P<0.001). Protective haplotypes (DR2)- DQA1*0102-B1*0602, (DR11/12/13)-DQA1*05-DQB1*0301, and (DR13)-DQA1*0103- DQB1*0603 were significantly more prevalent among controls than children with diabetes (25.6%, 33.3%, 19.2% vs. 0%, 3.2%, 0%; P<0.001). These frequencies are quite similar to those from neighbor countries with varying incidence of type 1 diabetes mellitus.
Conclusions. HLA class II haplotypes associated with type 1 diabetes mellitus positively or negatively were the same in Lithuanian children as in other European Caucasian populations. Differences in incidence and clinical manifestations of type 1 diabetes might be due to different environmental factors and/or lifestyle.
Keywords: type 1 diabetes mellitus; children; human leukocytes antigens; alleles; casecontrol study type 1 diabetes mellitus; children; human leukocytes antigens; alleles; casecontrol study
MDPI and ACS Style

Skrodenienė, E.; Marčiulionytė, D.; Padaiga, Ž.; Jašinskienė, E.; Sadauskaitė-Kuehne, V.; Sanjeevi, C.B.; Ludvigsson, J. HLA class II alleles and haplotypes in Lithuanian children with type 1 diabetes and healthy children (HLA and type 1 diabetes). Medicina 2010, 46, 505.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop